Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content

Eur Respir J. 2022 Jul 21;60(1):2101470. doi: 10.1183/13993003.01470-2021. Print 2022 Jul.

Abstract

Background: Mechanical stretch of cancer cells can alter their invasiveness. During mechanical ventilation, lungs may be exposed to an increased amount of stretch, but the consequences on lung tumours have not been explored.

Methods: To characterise the influence of mechanical ventilation on the behaviour of lung tumours, invasiveness assays and transcriptomic analyses were performed in cancer cell lines cultured in static conditions or under cyclic stretch. Mice harbouring lung melanoma implants were submitted to mechanical ventilation and metastatic spread was assessed. Additional in vivo experiments were performed to determine the mechanodependent specificity of the response. Incidence of metastases was studied in a cohort of lung cancer patients that received mechanical ventilation compared with a matched group of nonventilated patients.

Results: Stretch increases invasiveness in melanoma B16F10luc2 and lung adenocarcinoma A549 cells. We identified a mechanosensitive upregulation of pathways involved in cholesterol processing in vitro, leading to an increase in pro-protein convertase subtilisin/kexin type 9 (PCSK9) and LDLR expression, a decrease in intracellular cholesterol and preservation of cell stiffness. A course of mechanical ventilation in mice harbouring melanoma implants increased brain and kidney metastases 2 weeks later. Blockade of PCSK9 using a monoclonal antibody increased cell cholesterol and stiffness and decreased cell invasiveness in vitro and metastasis in vivo. In patients, mechanical ventilation increased PCSK9 abundance in lung tumours and the incidence of metastasis, thus decreasing survival.

Conclusions: Our results suggest that mechanical stretch promote invasiveness of cancer cells, which may have clinically relevant consequences. Pharmacological manipulation of cholesterol endocytosis could be a novel therapeutic target in this setting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Adenocarcinoma* / metabolism
  • Adenocarcinoma* / pathology
  • Animals
  • Cholesterol* / metabolism
  • Humans
  • Lung Neoplasms* / metabolism
  • Lung Neoplasms* / pathology
  • Melanoma* / metabolism
  • Melanoma* / pathology
  • Mice
  • Proprotein Convertase 9* / genetics
  • Proprotein Convertase 9* / metabolism
  • Receptors, LDL / metabolism
  • Respiration, Artificial* / adverse effects

Substances

  • Receptors, LDL
  • Cholesterol
  • PCSK9 protein, human
  • Pcsk9 protein, mouse
  • Proprotein Convertase 9